Allurion Technologies Inc (ALUR)
1.88
+0.02
(+1.08%)
USD |
NYSE |
May 17, 16:00
1.90
+0.02
(+1.06%)
After-Hours: 20:00
Allurion Technologies Research and Development Expense (Quarterly): 5.725M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 5.725M |
December 31, 2023 | 6.071M |
September 30, 2023 | 7.191M |
June 30, 2023 | 6.581M |
March 31, 2023 | 7.852M |
Date | Value |
---|---|
December 31, 2022 | 5.732M |
September 30, 2022 | 5.069M |
June 30, 2022 | 3.096M |
March 31, 2022 | 3.069M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
3.069M
Minimum
Mar 2022
7.852M
Maximum
Mar 2023
5.598M
Average
5.732M
Median
Dec 2022
Research and Development Expense (Quarterly) Benchmarks
Outset Medical Inc | 12.64M |
Paragon 28 Inc | 7.584M |
Perspective Therapeutics Inc | 7.452M |
Xtant Medical Holdings Inc | 0.527M |
Asensus Surgical Inc | 8.091M |